Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
Quick Stats
Jul 13, 202652.8
AI Score
HOLD0.41
Volume Ratio
Aug 04, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
FULC Stock Summary
Last updated Jul 13, 2026
FULC is currently trading at $3.54, positioned below its 200-day moving average of $8.35, suggesting bearish momentum. The stock has a 52-week range of $2.83 to $15.7399.
Technical Analysis: The 50-day moving average stands at $5.01, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.061, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.081, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates FULC at 52.8/100 with a HOLD recommendation.
FULC (Fulcrum Therapeutics, Inc. Common Stock) Indicators
Last updated Jul 13, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 36.061 |
| CMF (20) | -0.081 |
| ROC (10) | -6.842 |
| ADX (14) | 29.028 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.351 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -77.869 |
| MFI (14) | 55.034 |
FULC Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
FULC Price vs Max Options Open Interest
FULC Max Change In Options Open Interest
FULC Options - Sort by Max open Interest (near term)
13th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FULC Daily Out of Money Options - Sort by Max open Interest (near term)
13th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FULC Daily In the Money Options - Sort by Max open Interest (near term)
13th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FULC Most Active Options by Volume(near term)
13th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Fulcrum Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
FULC Moving Averages Analysis
FULC (Fulcrum Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jul 13, 2026
| Days | MA |
|---|---|
| 10 | 3.67 |
| 20 | 3.66 |
| 30 | 3.8 |
| 50 | 5.01 |
| 100 | 6.49 |
| 200 | 8.35 |
FULC Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 233.2 million |
| Earnings/Share ($) | -1.15 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.761 |
| EPS Estimate Next Year ($) | -0.5806 |
| WallStreet Target Price ($) | 5.8333 |
| Most Recent Quarter |